Cite
HARVARD Citation
He, Z. et al. (2017). Review of current evidence available for guiding optimal Enoxaparin prophylactic dosing strategies in obese patients—Actual Weight-based vs Fixed. Critical reviews in oncology/hematology. pp. 191-194. [Online].